(Q42855416)

English

Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series

scientific article published on November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

1 reference

based on heuristic

inferred from title

author name string

Matthew S Epstein

1

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Fredrick W Wicknick

2

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Joel B Epstein

3

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

James R Berenson

4

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Meir Gorsky

5

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

110

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

593-596

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Bisphosphonates for treatment and prevention of bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Possible association between diabetes and bisphosphonate-related jaw osteonecrosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Osteoradionecrosis of the mandible

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Practical aspects of management of recurrent aphthous stomatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Pentoxifylline in the treatment of radiation-related soft tissue injury: preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease--a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Vitamin E supplementation increases T helper 1 cytokine production in old mice infected with influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Pressure-induced skin lesions in pigs: reperfusion injury and the effects of vitamin E

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.05.067

7 January 2021

Identifiers

10.1016/J.TRIPLEO.2010.05.067

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42855416&oldid=1972763533"